1. Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study. (January 2022) Authors: Panhaleux, Marion; Espitia, Olivier; Terrier, Benjamin; Manson, Guillaume; Maria, Alexandre; Humbert, Sébastien; Godbert, Benoît; Perrin, Julie; Achille, Aurélie; Arrondeau, Jennifer; Kostine, Marie; Fallet, Vincent; Pugnet, Grégory; Chaigne, Benjamin; Champiat, Stéphane; Laparra, Ariane; Danlos,... Journal: European journal of cancer Issue: Volume 160(2022) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of lung cancers in patients with BRCA germline variants: A multicenter series. (November 2022) Authors: Sanchis-Borja, Mateo; Fallet, Vincent; Fabre, Elisabeth; Wislez, Marie; Culine, Stéphane; Zalcman, Gérard; Spano, Jean-Philippe; Buffet, Nathalie Chabbert; Coulet, Florence; Benusiglio, Patrick R.; Cadranel, Jacques Journal: Lung cancer Issue: Volume 173(2022) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study. Issue 7 (July 2020) Authors: Marquette, Charles-Hugo; Boutros, Jacques; Benzaquen, Jonathan; Ferreira, Marion; Pastre, Jean; Pison, Christophe; Padovani, Bernard; Bettayeb, Faiza; Fallet, Vincent; Guibert, Nicolas; Basille, Damien; Ilie, Marius; Hofman, Véronique; Hofman, Paul Journal: Lancet Issue: Volume 8:Issue 7(2020) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study. Issue 7 (July 2020) Authors: Marquette, Charles-Hugo; Boutros, Jacques; Benzaquen, Jonathan; Ferreira, Marion; Pastre, Jean; Pison, Christophe; Padovani, Bernard; Bettayeb, Faiza; Fallet, Vincent; Guibert, Nicolas; Basille, Damien; Ilie, Marius; Hofman, Véronique; Hofman, Paul; MARQUETTE, Charles-Hugo; BOUTROS, Jacques; Benz... Journal: Lancet Issue: Volume 8:Issue 7(2020) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. Issue 3 (March 2021) Authors: Mariette, Xavier; Hermine, Olivier; Resche-Rigon, Matthieu; Porcher, Raphael; Ravaud, Philippe; Bureau, Serge; Dougados, Maxime; Tibi, Annick; Azoulay, Elie; Cadranel, Jacques; Emmerich, Joseph; Fartoukh, Muriel; Guidet, Bertrand; Humbert, Marc; Lacombe, Karine; Mahevas, Matthieu; Pene, Frédéric;... Journal: Lancet Issue: Volume 9:Issue 3(2021) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer. Issue 2 (20th April 2018) Authors: Costantini, Adrien; Corny, Jennifer; Fallet, Vincent; Renet, Sophie; Friard, Sylvie; Chouaid, Christos; Duchemann, Boris; Giroux-Leprieur, Etienne; Taillade, Laurent; Doucet, Ludovic; Nguenang, Marina; Jouveshomme, Stéphane; Wislez, Marie; Tredaniel, Jean; Cadranel, Jacques Journal: ERJ open research Issue: Volume 4:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer. (9th October 2019) Authors: Cadranel, Jacques; Canellas, Anthony; Matton, Lise; Darrason, Marie; Parrot, Antoine; Naccache, Jean-Marc; Lavolé, Armelle; Ruppert, Anne-Marie; Fallet, Vincent Journal: European respiratory review Issue: Volume 28:Number 153(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages. (August 2016) Authors: Vieira, Thibault; Antoine, Martine; Hamard, Cécile; Fallet, Vincent; Duruisseaux, Michael; Rabbe, Nathalie; Rodenas, Anita; Cadranel, Jacques; Wislez, Marie Journal: Lung cancer Issue: Volume 98(2016) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages. (August 2016) Authors: Vieira, Thibault; Antoine, Martine; Hamard, Cécile; Fallet, Vincent; Duruisseaux, Michael; Rabbe, Nathalie; Rodenas, Anita; Cadranel, Jacques; Wislez, Marie Journal: Lung cancer Issue: Volume 98(2016) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial. (January 2022) Authors: Mariette, Xavier; Hermine, Olivier; Tharaux, Pierre-Louis; Resche-Rigon, Matthieu; Porcher, Raphael; Ravaud, Philippe; Bureau, Serge; Dougados, Maxime; Tibi, Annick; Azoulay, Elie; Cadranel, Jacques; Emmerich, Joseph; Fartoukh, Muriel; Guidet, Bertrand; Humbert, Marc; Lacombe, Karine; Mahevas, Ma... Journal: Lancet Issue: Volume 4:Number 1(2022) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗